A digital approach in the rapid response to COVID-19 - Experience of a paediatric institution

Daryl R Cheng1, Andrew Coote2, Mike South1

  • 1Department of General Medicine, The Royal Children's Hospital Melbourne, Parkville, Australia; EMR Project Team, The Royal Children's Hospital Melbourne, Parkville, Australia; Department of Paediatrics, University of Melbourne, Australia; Murdoch Children's Research Institute, Parkville, Australia.

Insights

The Royal Children's Hospital Melbourne rapidly adopted digital health solutions, including electronic medical records and telehealth, to manage COVID-19 patient care. This digital transformation enhanced healthcare delivery and enabled remote work for clinicians.

Area of Science:

  • Digital Health
  • Health Informatics
  • Healthcare Management

Background:

  • The COVID-19 pandemic necessitated rapid changes in healthcare delivery across Australia.
  • A tertiary pediatric institution, The Royal Children's Hospital Melbourne (RCH), implemented a comprehensive digital health strategy.
  • This strategy centered on optimizing an integrated electronic medical record (EMR) system.

Purpose of the Study:

  • To outline the key aspects of the COVID-19 digital health strategy implemented at RCH.
  • To highlight the rapid transition to telehealth services.
  • To describe the development of a remote virtual telehealth strategy for clinicians.

Main Methods:

  • Implementation of a broad suite of informatics and technology solutions.
  • Optimization of a fully integrated electronic medical record (EMR).
  • Development and deployment of telehealth services, including a remote virtual model.

Main Results:

  • Successful integration of digital health across all patient care areas and hospital operations.
  • Rapid transition to telehealth, enabling remote consultations and clinical operations.
  • Development of a popular "virtual telehealth" strategy facilitating clinician remote work.

Conclusions:

  • COVID-19 accelerated the adoption and highlighted the utility of digital health in clinical care.
  • The rapid implementation of digital health solutions was unprecedented in Australia and globally.
  • Future digital health strategies should consider identified stakeholders and enablers for sustained governance and adoption post-pandemic.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
330
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
101
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
122